Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03560830 · ClinicalTrials.gov registry record
START & STOPP in GWI
A clinical trial, sponsored by Georgetown University.
- Completed
- Registry status
- 52
- Enrollment target
NCT03560830: Completed study, sponsored by Georgetown University.
NCT03560830 is a clinical trial that has completed, run by Georgetown University. The registered enrollment target is 52 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03560830 has completed, sponsored by Georgetown University.
- COMPLETED
- Registry status
- 52 participants
- Enrollment target
Study Summary
Gulf War Illness (GWI) veterans were divided into 2 pathophysiological groups based on their orthostatic tachycardia responses after submaximal exercise. Two thirds had normal increases of 10 to 15 beats per minute between recumbent and standing both before and after exercise. These were termed the Stress Test Originated Phantom Perception (STOPP) phenotype. In contrast, one third had increases in heart rate of more than 30 beats per minute indicating that exercise induced postural tachycardia; there were the Stress Test Activated Reversible Tachycardia (START) group. This study aimed to confirm the original findings of Rayhan (2013).
Primary Outcome
Delta heart rate (deltaHR) greater than 30 beats per minute within 48 hr of performing submaximal exercise stress test
Interventions
- OTHER 2 submaximal exercise stress tests
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2016-02 |
| Est. Completion | 2019-06-18 |
What the finished NCT03560830 record still lists
NCT03560830 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 52 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which 2 submaximal exercise stress tests is the first listed.
NCT03560830 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03560830 about?
NCT03560830 is a clinical study titled "START & STOPP in GWI". Gulf War Illness (GWI) veterans were divided into 2 pathophysiological groups based on their orthostatic tachycardia responses after submaximal exercise. Two thirds had normal increases of 10 to 15 beats per minute between recumbent and standing both before and after exercise. These were termed the ...
What is the current status of trial NCT03560830?
This trial is currently completed. The enrollment target is 52 participants. The study started on 2016-02. Estimated completion is 2019-06-18.
What interventions are being tested in trial NCT03560830?
The interventions under investigation include: 2 submaximal exercise stress tests (OTHER).
Who is sponsoring clinical trial NCT03560830?
This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02630121 · 52 participants · Phase 4
Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea
- NCT03629171 · 52 participants · Phase 2
Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia
- NCT04128748 · 52 participants · Phase 1
Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome
- NCT04150497 · 52 participants · Phase 1
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia